Application of HLA class II transgenic mice to study autoimmune regulation

Thyroid

Volumn 17, Issue 10, 2007, Pages 995-1003

  Kong, Yi Chi M ^a   Flynn, Jeffrey C ^a   Banga, J Paul ^b   David, Chella S ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HLA ANTIGEN CLASS 2; IODINE; PLASMID DNA; THYROGLOBULIN; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN;

ALLELE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CELL MANIPULATION; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC REGULATION; HLA SYSTEM; HUMAN; IMMUNIZATION; IMMUNOREGULATION; INCIDENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION; TRANSGENIC MOUSE; TUMOR IMMUNITY;

ANIMALS; AUTOIMMUNITY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IODIDE PEROXIDASE; IODINE; MICE; MICE, TRANSGENIC; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES, REGULATORY; THYROIDITIS, AUTOIMMUNE;

EID: 35948954293     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0196     Document Type: Review

References (39)

1. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D 1991 Mice lacking MHC class II molecules. Cell 66:1051-1066.
2. Strauss G, Vignali DAA, Schönrich G, Hämmerling GJ 1994 Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics 40:104-108.
3. Vladutiu AO, Rose NR 1971 Autoimmune murine thyroiditis: relation to histocompatibility (H-2) type. Science 174:1137-1139.
4. Kong YM, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hämmerling GJ, David CS 1996 HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184:1167-1172.
5. Vaidya B, Kendall-Taylor P, Pearce SHS 2002 Genetics of endocrine disease: the genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 87:5385-5397.
6. Taneja V, David CS 1999 HLA class II transgenic mice as models of human diseases. Immunol Rev 169:67-79.
7. Kong YM, David CS, Lomo LC, Fuller BE, Motte RW, Giraldo AA 1997 Role of mouse and human class II transgenes in susceptibility to and protection against mouse autoimmune thyroiditis. Immunogenetics 46:312-317.
8. Wan Q, Shah R, Panos JC, Giraldo AA, David CS, Kong YM 2002 HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible. Hum Immunol 63:301-310.
9. Flynn JC, Fuller BE, Giraldo AA, Panos JC, David CS, Kong YM 2001 Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice. J Autoimmun 17:7-15.
10. Flynn JC, Wan Q, Panos JC, McCormick DJ, Giraldo AA, David CS, Kong YM 2002 Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis. J Autoimmun 18:213-220.
11. Segni M, Pani MA, Pasquino AM, Badenhoop K 2002 Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. J Clin Endocrinol Metab 87:3779-3782.
12. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L, McDevitt HO 1988 A molecular basis for MHC class II-associated autoimmunity. Science 240:1003-1009.
13. Kong YM, Flynn JC, Wan Q, David CS 2003 HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36:397-404.
14. Carayanniotis G, Kong YM 2000 Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis. Int Rev Immunol 19:557-572.
15. Caturegli P, Vidalain PO, Vali M, Aguilera-Galaviz LA, Rose NR 1997 Cloning and characterization of murine thyroglobulin cDNA. Clin Immunol Immunopathol 85:221-226.
16. Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YM 2004 Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol 229:79-85.
17. Karras E, Yang H, Lymberi P, Christadoss P 2005 Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice. J Autoimmun 24:291-296.
18. Banga JP 2007 The long and winding road for an experimental model of hyperthyroid Graves' disease. In: Wiersinga WM, Drexhage HA, Weetman AP (eds) The Thyroid and Autoimmunity. Georg Thieme Verlag, Stuttgart, Germany, pp 118-125.
19. Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP 2004 Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin Exp Immunol 137:503-512.
20. Guo J, McLachlan SM, Pichurin PN, Chen C-R, Pham N, Aliesky HA, David CS, Rapoport B 2005 Relationship between thyroid peroxidase T cell epitope restriction and antibody recognition of the autoantibody immunodominant region in human leukocyte antigen DR3 transgenic mice. Endocrinology 146:4961-4967.
21. Flynn JC, Rao PV, Gora M, Alsharabi G, Wei W, Giraldo AA, David CS, Banga JP, Kong YM 2004 Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA. Clin Exp Immunol 135:35-40.
22. Flynn JC, Gilbert JA, Meroueh C, Snower DP, David CS, Kong YM, Banga JP 2007 Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice. Immunology 122:261-267.
23. Kaneda T, Honda A, Hakozaki A, Fuse T, Muto A, Yoshida T 2007 An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology 148:2335-2344.
24. Pichurin P, Chen C-R, Pichurina O, David C, Rapoport B, McLachlan SM 2003 Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. Thyroid 13:911-917.
25. + regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell Immunol 226:20-29.
26. + regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J Immunol 174:3111-3116.
27. + regulatory T cells influence susceptibility but do not supersede MHC class II restriction. Front Biosci 11:1234-1243.
28. + T cells are required for iodine accelerated thyroiditis in NOD mice. Cell Immunol 192:113-121.
29. Braley-Mullen H, Sharp GC, Medling B, Tang H 1999 Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 12:157-165.
30. Rasooly L, Burek CL, Rose NR 1996 Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 81:287-292.
31. + regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leukocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 147:547-554.
32. + T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J Exp Med 203:349-358.
33. Wei W-Z, Morris GP, Kong YM 2004 Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53:73-78.
34. + regulatory T cell-depleted mice. Cancer Res 65:8471-8478.
35. Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM 2005 Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 28:593-598.
36. McNeel DG, Knutson KL, Schiffman K, Davis DR, Caron D, Disis ML 2003 Pilot study on an HLA-A2 peptide vaccine using Flt3 ligand as a systemic vaccine adjuvant. J Clin Immunol 23:62-72.
37. Jacob JB, Kong YM, Meroueh C, Snower DP, David CS, Ho Y-S, Wei W-Z 2007 Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res 67:7020-7027.
38. Madsen L, Labrecque N, Engberg J, Dierich A, Svejgaard A, Benoist C, Mathis D, Fugger L 1999 Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 96:10338-10343.
39. Ban Y, Tomer Y 2005 Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 12:47-58.